Rohowsky-Kochan C, Molinaro D, Cook S D
Department of Neurosciences, University of Medicine & Dentistry of New Jersey, New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey, NJ 07103, USA.
Mult Scler. 2000 Apr;6(2):69-77. doi: 10.1177/135245850000600203.
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system with a presumed autoimmune pathogenesis involving autoantigen-specific CD4+ T cells and cytokines. A similar frequency of T cells responding to myelin basic protein (MBP), a putative target in MS, has been observed in MS patients and controls. To dissect the differences between MBP-specific T cells in patients and controls, we have analyzed the cytokine secretion profile of such autoreactive T cells. MBP-specific T cell clones (TCC) were isolated from the peripheral blood of MS patients and controls by limiting dilution. Expression of mRNA for interferon-gamma (IFN-gamma), interleukin (IL)-4, IL-10, tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) was assessed by polymerase chain reaction whereas secretion of cytokine protein was measured by ELISA. MBP-specific TCC exhibited a heterogeneous cytokine secretion profile with clones displaying Th1, Th2 and Th0 phenotypes. A significant difference in the distribution of the cytokine profile was noted between MS patients and controls. Although the frequency of Th1 secreting MBP-reactive TCC was similar between MS patients and controls, stable MS patients had a significant association with the Th0 phenotype whereas healthy individuals were associated with the Th2 phenotype. In comparison to control TCC, MBP-specific TCC from MS patients secreted increased amounts of IFN-gamma, IL-4 and IL-10 and decreased quantities of TGF-beta. Thus, these studies suggest that there is a dysregulation in the balance between pro-inflammatory Th1 and anti-inflammatory Th2 cytokines in MS. It appears that the presence of Th1 secreting autoreactive T cells in healthy individuals may be counterbalanced by the presence of cells secreting Th2 cytokines and by the augmented production of the immunosuppressive cytokine TGF-beta, whereas in MS there is a decrease in these anti-inflammatory agents.
多发性硬化症(MS)是一种中枢神经系统的脱髓鞘疾病,其发病机制推测为自身免疫性,涉及自身抗原特异性CD4 + T细胞和细胞因子。在MS患者和对照中观察到对髓鞘碱性蛋白(MBP,MS中的一个假定靶点)产生反应的T细胞频率相似。为了剖析患者和对照中MBP特异性T细胞之间的差异,我们分析了此类自身反应性T细胞的细胞因子分泌谱。通过有限稀释从MS患者和对照的外周血中分离出MBP特异性T细胞克隆(TCC)。通过聚合酶链反应评估干扰素-γ(IFN-γ)、白细胞介素(IL)-4、IL-10、肿瘤坏死因子-α(TNF-α)和转化生长因子-β(TGF-β)的mRNA表达,而通过ELISA测量细胞因子蛋白的分泌。MBP特异性TCC表现出异质性的细胞因子分泌谱,克隆呈现Th1、Th2和Th0表型。注意到MS患者和对照之间细胞因子谱的分布存在显著差异。尽管MS患者和对照之间分泌MBP反应性TCC的Th1频率相似,但稳定的MS患者与Th0表型有显著关联,而健康个体与Th2表型相关。与对照TCC相比,来自MS患者的MBP特异性TCC分泌的IFN-γ、IL-4和IL-10量增加,而TGF-β量减少。因此,这些研究表明MS中促炎性Th1和抗炎性Th2细胞因子之间的平衡存在失调。似乎健康个体中分泌Th1的自身反应性T细胞的存在可能被分泌Th2细胞因子的细胞的存在以及免疫抑制细胞因子TGF-β的增加产生所抵消,而在MS中这些抗炎剂减少。